Study of Orally Administered AG-120 in Subjects With Advanced Solid Tumors, Including Glioma, With an IDH1 Mutation
Clinical trial NCT02073994 · COMPLETED
Trial details
- NCT number
- NCT02073994
- Sponsor
- Institut de Recherches Internationales Servier
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-01
- Primary completion
- 2024-01-04
- Enrollment
- 174
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.